1. Home
  2. IRD vs GTEC Comparison

IRD vs GTEC Comparison

Compare IRD & GTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • GTEC
  • Stock Information
  • Founded
  • IRD 2018
  • GTEC 2006
  • Country
  • IRD United States
  • GTEC United States
  • Employees
  • IRD N/A
  • GTEC N/A
  • Industry
  • IRD
  • GTEC Industrial Machinery/Components
  • Sector
  • IRD
  • GTEC Industrials
  • Exchange
  • IRD NYSE
  • GTEC Nasdaq
  • Market Cap
  • IRD 36.0M
  • GTEC 32.2M
  • IPO Year
  • IRD N/A
  • GTEC N/A
  • Fundamental
  • Price
  • IRD $1.14
  • GTEC $2.23
  • Analyst Decision
  • IRD Strong Buy
  • GTEC
  • Analyst Count
  • IRD 1
  • GTEC 0
  • Target Price
  • IRD $8.00
  • GTEC N/A
  • AVG Volume (30 Days)
  • IRD 144.6K
  • GTEC 387.9K
  • Earning Date
  • IRD 02-19-2025
  • GTEC 11-14-2024
  • Dividend Yield
  • IRD N/A
  • GTEC N/A
  • EPS Growth
  • IRD N/A
  • GTEC N/A
  • EPS
  • IRD N/A
  • GTEC N/A
  • Revenue
  • IRD $8,381,000.00
  • GTEC $87,352,614.00
  • Revenue This Year
  • IRD N/A
  • GTEC N/A
  • Revenue Next Year
  • IRD $29.37
  • GTEC $1.70
  • P/E Ratio
  • IRD N/A
  • GTEC N/A
  • Revenue Growth
  • IRD N/A
  • GTEC 0.76
  • 52 Week Low
  • IRD $0.81
  • GTEC $1.36
  • 52 Week High
  • IRD $2.71
  • GTEC $3.69
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • GTEC 47.79
  • Support Level
  • IRD N/A
  • GTEC $2.20
  • Resistance Level
  • IRD N/A
  • GTEC $2.54
  • Average True Range (ATR)
  • IRD 0.00
  • GTEC 0.23
  • MACD
  • IRD 0.00
  • GTEC -0.03
  • Stochastic Oscillator
  • IRD 0.00
  • GTEC 9.21

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of innovative and quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

Share on Social Networks: